To meaningfully scale mental health care — and improve outcomes along the way — we must move beyond the rigid constraints of episodic care and toward a model that is continuous, intelligent, and adaptive to individual needs. The post Beyond the Session: A Smarter Mental Health Model appeared first on MedCity News.
Pharma leaders must take a “construction crew” mindset and start treating workforce development in the same manner as they do critical infrastructure. The post The Real Bottleneck in U.S. Pharma Reshoring Isn’t Factories – It’s Talent appeared first on MedCity News.
For field providers, the goal isn’t just faster paperwork — it’s smarter, safer documentation that puts patient care first. The post Reducing EMS Documentation Time Without Sacrificing Accuracy appeared first on MedCity News.
As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers are becoming increasingly blurry. The post It Is Time For The Life Sciences Industry To Rethink Its Relationship with HIPAA appeared first on MedCity News.
California Gov. Gavin Newsom, who is eyeing a presidential bid, has incensed both Democrats and Republicans over immigrant health care in his home state, underscoring the delicate political path ahead. For a second year, the Democrat has asked state lawmakers to roll back coverage for some immigrants in the face of federal Medicaid spending cuts…
This brief reports on community health center patients, services, experiences, and financing in 2023 and analyzes changes from 2019 (pre-pandemic) through 2023 using data from the Uniform Data System (UDS) and the 2022 Health Center Patient Survey.
By integrating AI with human oversight, Reimagine Care aims to enhance virtual oncology care
Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to infants and young children. Kresladi is the first gene therapy for this ultra-rare disease and the first commercial product for Rocket. The post FDA Approval Makes Rocket Pharma Gene Therapy…
By DAVID SHAYWITZ Our current system of delivering care is awful from the perspective of seemingly every stakeholder. It frustrates, enrages, saddens, and depletes patients and physicians alike. No one designed it this way. It evolved through a series of choices and contingencies that perhaps made sense at the time but now seem to have…
Medicaid and CHIP facilitate necessary access to oral health services, which helps to bridge the gap in dental care for children from low- and moderate-income families. By providing coverage, it ensures that socioeconomic status does not hinder a child’s ability to receive necessary dental services. The post The Evolving Landscape of Medicaid and CHIP: Implications…